REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $498,000 | -10.8% | 6,490 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $558,000 | +45.7% | 6,490 | 0.0% | 0.01% | +40.0% |
| Q1 2019 | $383,000 | +12.0% | 6,490 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $342,000 | -5.0% | 6,490 | 0.0% | 0.01% | +11.1% |
| Q3 2018 | $360,000 | +24.1% | 6,490 | +5.4% | 0.01% | +28.6% |
| Q2 2018 | $290,000 | +30.0% | 6,160 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $223,000 | +21.2% | 6,160 | +21.7% | 0.01% | +20.0% |
| Q4 2017 | $184,000 | +15.0% | 5,060 | +21.1% | 0.01% | 0.0% |
| Q3 2017 | $160,000 | +18.5% | 4,180 | +28.4% | 0.01% | +25.0% |
| Q2 2017 | $135,000 | +141.1% | 3,256 | +105.6% | 0.00% | +100.0% |
| Q1 2017 | $56,000 | +24.4% | 1,584 | +9.1% | 0.00% | +100.0% |
| Q4 2016 | $45,000 | – | 1,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |